Researchers assessed the risk for major adverse cardiovascular events in patients with psoriatic arthritis receiving treatment with different classes of DMARDs.
A case study of a patient who developed an acute gout flare of bilateral first metatarsophalangeal joints after initiating treatment with ibrutinib for chronic lymphocytic leukemia.
Researchers evaluated the efficacy of guselkumab in patients with psoriatic arthritis with imaging-confirmed sacroiliitis consistent with axial involvement.
Researchers evaluated the association between Assessment of Spondyloarthritis International Society Health Index (ASAS-HI) and disease activity and burden in patients with spondyloarthritis.
Researchers analyzed cardiovascular risk comorbidities among patients with rheumatoid arthritis, and the correlation between CV risk and the use of antirheumatic drugs.
Researchers aimed to study the correlation between irreversible organ damage and quality of life in systemic lupus erythematosus, and to identify the type of organ damage that is negatively correlated with QOL.
